Mohammad Amin Najafi
Overview
Explore the profile of Mohammad Amin Najafi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Afshar F, Khalilian M, Pourazizi M, Najafi M
BMC Ophthalmol
. 2025 Jan;
25(1):23.
PMID: 39825304
Herpes zoster Ophthalmicus (HZO) affecting the ophthalmic division (V1) of the trigeminal nerve. HZO may cause extraocular muscle palsies, with the third nerve being the most commonly affected and the...
2.
Khademian M, Shahsavari A, Qorbani M, Motlagh M, Heshmat R, Khozani E, et al.
Adv Biomed Res
. 2024 Oct;
13:65.
PMID: 39434948
Background: This study aims to evaluate the association of beverage consumption with cardiometabolic risk factors and alanine transaminase (ALT) levels in children and adolescents. Materials And Methods: This nationwide study...
3.
Saadatnia M, Norouzi R, Najafi M, Gol Parvar S, Najafian A, Tabatabei A, et al.
Front Neurol
. 2024 Oct;
15:1420675.
PMID: 39350972
Background: Opium use disorder is a significant health problem in our country, leading to a considerable number of health issues. Opium has several detrimental effects on its consumers. However, the...
4.
Najafi M, Zandifar A, Kheradmand M, Tierradentro-Garcia L, Khorvash F, Vossough A, et al.
Curr J Neurol
. 2023 Nov;
22(3):170-178.
PMID: 38011454
Cerebrovascular diseases comprise a significant portion of neurological disorders related to coronavirus disease 2019 (COVID-19). We evaluated the clinical and imaging characteristics of a cohort of COVID-19 patients with stroke...
5.
Paymannejad S, Shirani K, Najafi M, Khorvash F, Shamlou F
Clin Case Rep
. 2023 Oct;
11(10):e7993.
PMID: 37808572
Epstein-Barr virus (EBV) is a commonly asymptomatic widespread human herpes virus affecting over 90% of the population. It mostly originates complications like simple sore throat and infectious mononucleosis but severe...
6.
Najafi M, Zandifar A, Ramezani N, Paydari H, Kheradmand M, Ansari B, et al.
Clin Neuroradiol
. 2022 Dec;
33(2):499-507.
PMID: 36520187
Purpose: The aim of this study was to compare clinical, neuroimaging, and laboratory features of rhino-orbito-cerebral mucormycosis (ROCM) in COVID-19 patients with and without ischemic stroke complications. Methods: This observational...
7.
Ghadimi K, Heidari Z, Kheradmand M, Najafi M, Chitsaz A, Khorvash F, et al.
Am J Neurodegener Dis
. 2022 Nov;
11(3):46-54.
PMID: 36419954
Background: COVID-19 is the cause of the recent pandemic. Viral infections could increase the risks of neurological impairments, including seizures. Here, we aimed to evaluate the prevalence, clinical, imaging, electroencephalography...
8.
Kheradmand M, Hemasian H, Khorvash F, Najafi M, Ghadimi K, Forouharnejad K, et al.
Am J Neurodegener Dis
. 2022 Jul;
11(2):34-45.
PMID: 35874940
Complications are increasingly recognized with SARS-CoV-2, the causative pathogen for COVID-19. Various mechanisms have been proposed to justify the cause of seizures in Covid-19 patients. To our knowledge, 13 cases...
9.
Khorvash F, Najafi M, Kheradmand M, Saadatnia M, Chegini R, Najafi F
J Res Med Sci
. 2022 May;
27:31.
PMID: 35548177
Background: Neurological manifestations of coronavirus disease 2019 (COVID-19) have been highlighted. COVID-19 potentially increases the risk of thromboembolism. We aimed to compare patients with COVID-19 with and without new-onset acute...
10.
Najafi M, Najafi M, Shayan-Moghadam R, Saadatpour Z, Ghadimi K
Am J Clin Exp Immunol
. 2020 Nov;
9(4):58-63.
PMID: 33235821
Background: Carbamazepine is a first line treatment for focal epilepsy. Tegretol and Tegatard are two trade name of Carbamazepine. Tegretol is produced by Novartis Pharmaceutical Company, Switzerland. Recently, Raha pharmaceutical...